Cassava Sciences | PTIE - Debt


Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Abbott USD 13.86B 919M Dec/2025
Amgen USD 54.59B 1.62B Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 236.67B 49.14B Sep/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Geron USD 121.92M 73K Sep/2025
J&J USD 47.93B 2.14B Dec/2025
Merck USD 41.37B 5.97B Sep/2025
Novartis USD 35.38B 2.74B Dec/2025
Novavax USD 233.31M 4.23M Sep/2024
Pfizer USD 60.85B 78M Sep/2025
Roche Holding CHF 33.03B 1.41B Jun/2025